// App-Quantinova.ai

2225 : Effect Of Blood Transfusion Therapy On Coagulation Activation In Sickle Cell Disease Patients With High TCD Velocity

Researchers

Presenter

  • Hyacinth Idu Hyacinth

Principal Investigators

  • Robert J. Adams

  • Jacqueline Hibbert

  • Beatrice E Gee

Medical Centers

  • Department of Neuroscience, Medical University of South Carolina, Charleston, SC

  • Children's Healthcare of Atlanta, Atlanta, GA

  • Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA

  • Stroke Center/Medical University of South Carolina, Charleston, SC

  • Morehouse School of Medicine, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute chest syndrome

  • Sickle cell anemia

  • Venous thrombosis

  • Stroke

Biomarkers

  • Alpha-tubulin N-acetyltransferase 1

  • Soluble Vascular Cell Adhesion Molecule-1

  • Stearoyl-CoA desaturase

  • von Willebrand factor

Drug/Treatment

  • Evithrom

  • Becaplermin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim